Thought Leadership
Insight

Let’s Chat About Chatbots: Part 2

In our last post, we discussed how business are deploying and benefiting from chatbots. Now that you have a basic understanding of what chatbots are and how they work, the next step is implementing them into your business model. For life sciences companies that are unsure of...
Insight

What Do You Need to Know About Digital Marketing For Life Sciences in 2022?

There have been many consequences and unexpected changes for marketers since the start of the COVID-19 pandemic. One of them (especially in the life sciences arena) is the concept of forced innovation. As an industry, life sciences had traditionally been slow to embrace a fully...
Insight

Digital Health Tools and Patient Support in China

Digital health has been a trending topic in the life sciences space, and has gained particular momentum due to the COVID-19 outbreak. In 2020, the global digital health market was valued at over $141.8 billion. This is expected to increase in value at a compound annual...
Insight

Does a One-Stop-Shop Global Translation Provider Truly Exist?

Within the global translation market, there are over 200 global language service providers (LSPs), each reporting annual revenues larger than $1 million. Collectively, the 2020 revenue of all 200 companies equates to approximately $8 billion. All of these LSPs have...
Insight

5 Key Considerations for Implementing Digital Technologies to Support Patients in China

Patient support is a hot topic in the life sciences space. Healthcare providers are consistently looking for ways to improve patient care and better support patients’ needs. In our previous post, we discussed how China was paving the way in leveraging digital health technologies...
Insight

5 Key Benefits of Linking Reporting to Your TMS

In the clinical world, monitoring and reviewing the status of translations across multiple countries has consistently been a challenge. Managing multilingual clinical trial documents such as patient recruitment materials and meeting country-specific regulatory...
Insight

C3 Summit Recap: Shaping the Future of eCOA/ePRO Highlights

The paper to digital migration of eCOAs/ePROs has been quite the journey, particularly in light of COVID-19. The rapid shift to decentralized clinical trials required pharma companies and CROs to adapt data capture techniques quickly while remaining compliant with local...
Insight

How Translation Can Increase Patient Engagement

As clinical research continues to expand across diverse markets and regions, it is imperative for data to reflect the global population. Data that is representative of all patients, including those of diverse backgrounds, ensures that the medical product in development serves and...
Insight

How CCMS Helps Healthcare Companies Prepare and Translate Medicare Compliance Content

In the United States, the Centers for Medicare & Medicaid Services (abbreviated "CMS" and found online at https://www.cms.gov/) aspires to the following credo:“We pledge to put patients first in all of our programs – Medicaid, Medicare, and the Health Insurance Exchanges. To do...
Insight

TransPerfect MT Earns Top Marks at International Machine Translation Competition

As machine translation (MT) technology continues to evolve, it’s increasingly important to look beyond the commercial sphere for the latest in innovation. At TransPerfect, we place special emphasis on the importance of engaging with the research communities specializing in MT...
Insight

Lay Summary Development: The Oregon Trail of Regulatory Writing

The Oregon Trail: one of the most iconic and cherished computer games of all time, filled with boxy graphics, heartache, and the occasional bout of dysentery. Players took on the role of wagon party leader, navigating the unchartered frontier of the Wild West in 1848—all the way...
Insight

Digital Strategies for Patient Recruitment

Patient recruitment is a huge spend in the life sciences. In fact, the market is projected to be worth approximately $30 billion USD by 2030. For life science companies conducting clinical trials, adapting patient recruitment strategies, including utilizing digital campaigns, can...
Insight

3 Translation Methodologies for Life Sciences Documentation

Translation is a complex endeavor, particularly in life sciences. Translation workflows, from receiving the document to delivering the final product, have multiple steps that must be followed with utmost accuracy.There is no one-size-fits-all model when translating clinical...
Insight

The Benefits of Translation Memory for Low-Cost Markets and Life Sciences Companies

For life sciences companies expanding into new markets and conducting global clinical trials, accurate translation is critical for effectively communicating with patients. Companies are continually looking for ways to reduce costs and turnaround times of translating extensive...
Insight

5 Ways to Increase Diversity in Medical Product Development

Over the past decade, there has been a critical push for more inclusive clinical trials. Many regulatory bodies, including the US Food and Drug Administration (FDA), require clinical trial data to ensure a medical product’s safety and efficacy prior to approving new treatments....
Insight

How TMF Study Owners Can Provide Better TMF Management

Successful trial master file (TMF) management requires constant and careful attention to each process, procedure, and guideline. This ensures a TMF is completely up-to-date, compliant, and ready for inspection at a moment’s notice. You know that maintaining high TMF quality is...
Insight

Language Landscape: Latin America

As Latin America (LATAM) is becoming a key market for pharmaceutical companies, the need to connect with the patient population there has increased as well.But is translating your content from English to Spanish LATAM the right approach?As simple as this question may seem, the...
Insight

Preparing Compliant eCTD Submissions in Asia

In May 2015, the US FDA published final and binding guidance requiring submission within 24 months of certain Common Technical Documents (CTDs) in an electronic format. This was ratified in 2017 and subsequently revised in February 2020 (Rev. 7). Currently, other notifying bodies...
Insight

Preparing and Publishing a Scientific Manuscript

If you’re preparing to write a scientific report for a peer-reviewed journal, it’s critical to have a detailed plan before beginning the first draft of your manuscript. Following the correct format and general guidance for manuscript writing is a good start, but there...
Insight

How to Choose and Implement a CTMS

The clinical development landscape is awash in technologies that automate everything from subject randomization (IVR/IWR) and subject study assessments and outcomes (EDC, ePRO) to trial master file (TMF) solutions.If you are like many emerging small to mid-sized biotech and...
Insight

How Life Sciences Companies Can Detect Adverse Events on Social Media

Pharmaceutical companies have historically relied on email correspondences, company websites, and physician hotlines as adverse event reporting channels. However, the incredibly high usage of social media means it is no longer a channel that can be ignored. Although safety...
Insight

The Summary of Safety and Clinical Performance (SSCP) for Healthcare Professionals and Patients

In 2017, the European Parliament and the Council of the European Union (EU) set a regulatory upgrade on medical devices to strengthen governance structure. This regulation update includes increased oversight of notified bodies, new requirements for transparency and traceability,...
Insight

5 Common eCOA Migration Issues

With so many clinical trials now using COAs on electronic platforms, the practice of “migration” (transferring and adapting COAs for electronic use) has become more common than ever. Without careful implementation, one minor deviation can compound across many languages, leading...
Insight

Driving Fundamentals: Ensuring an Efficient Clinical Research Process

My daughter is learning how to drive. In the U.S., driving a car is almost part of our DNA. For most of us, we learn to drive in our late teens and then continue to drive for the majority of the rest of our lives. At some point, we sort of forget we had to learn how to do it. As...